BP
Bharat Petroleum Corporation
Q4 FY25 · Diversified
BPCL reported Q4 FY25 revenue of INR 1,26,865 crore and PAT of INR 3,214 crore, supported by strong refining throughput of 10.58 MMT (121% capacity) and GRM of $9.2/bbl (premium of $3.16/bbl over Singapore). Marketing sales grew 1.82% YoY to 13.42 MMT, with record annual lubricant sales of 472 TMT. The company maintained a healthy balance sheet with net debt-to-equity of 0.13. Management guided for FY26 CapEx of INR 20,000 crore, rising to INR 30,000 crore by FY28, driven by CGD, Mozambique, and petrochemical projects. LPG under-recovery remains a drag at ~INR 170/cylinder, though a government mechanism is hoped for. Key risk: sustained LPG under-recovery without compensation could pressure cash flows amid elevated CapEx.
- Guidance read
- FY26 CapEx of INR 20,000 crore: Capital expenditure for FY26 is budgeted at INR 20,000 crore, with INR 5,900 crore for refineries, INR 5,600 crore for marketing, and INR 2,400 crore for pipelines. CapEx ramp-up to INR 30,000 crore by FY28: Management expects CapEx to increase to INR 25,000 crore in FY27 and INR 30,000 crore in FY28, excluding the Andhra Pradesh greenfield project. GRM guidance of $7-$9/bbl: Assuming current spreads and Russian discounts of ~$3/bbl continue, management expects GRMs in the $7-$9/bbl range. Mozambique project restart by July 2025: Operator expects force majeure to be lifted by July 2025, with project completion targeted by July 2028.
- Risk read
- Key risks include LPG under-recovery without compensation — LPG under-recovery is ~INR 170/cylinder, costing INR 650-700 crore per month. No government compensation mechanism has been announced, which could pressure cash flows.; Russian crude discount compression — Russian crude discounts have narrowed to ~$3/bbl from $8/bbl a year ago. Further compression could reduce refining margins, especially as new buyers (Turkey, Syria) emerge.; Mozambique project cost overruns — Project cost has escalated from $15.4 billion to an estimated $19.4 billion. Further delays or cost increases could impact BPCL's investment returns.; Market share loss in retail fuels — BPCL has lost some market share in petrol and diesel due to aggressive private sector competition. Management expects recovery through network expansion, but near-term pressure persists..
- Promise ledger
- Scorecard data is being built as historical quarters are processed.
BA
Bajajfinsv
Q4 FY25 · Diversified
Bajaj Finserv reported a steady Q4 FY25 with consolidated total income up 14% YoY to INR 36,596 crore and PAT up 14% to INR 2,417 crore. The general insurance arm BAGIC saw GWP decline 13% due to accounting changes and volatile crop/government health business, but core retail and commercial lines grew 8-12%, outpacing the industry. Life insurance arm BALIC delivered a strong VNB margin expansion to 22.1% (up ~400bps YoY) driven by product mix shift and cost actions, though PAT fell 61% on lower realized gains. Bajaj Finance continued robust performance with AUM growth of 26% and stable asset quality. Management expressed cautious optimism for H2 FY26, focusing on profitable growth and cost efficiencies. Key risks include regulatory changes, competitive pressure in insurance, and potential market volatility impacting investment gains.
- Guidance read
- BALIC VNB margin trajectory to steepen: Management expects VNB margin expansion to accelerate, with benefits from cost actions and product mix fully playing out by FY27, but visible from H2 FY26. BALIC top-line growth to pick up from H2 FY26: After a muted H1 due to high base and agency channel reset, growth is expected to recover in the second half of FY26. BAGIC to continue calibrated growth with underwriting focus: Management aims to maintain profitable growth, prioritizing underwriting performance over market share in tender-driven businesses. Platform businesses to scale transactions: Bajaj Finserv Health and Bajaj Markets are expected to increase transaction volumes and achieve greater scale, with health targeting international expansion.
- Risk read
- Key risks include Regulatory changes impacting insurance accounting — The 1/n regulation for long-term products distorted GWP and combined ratio comparability, and further regulatory shifts could affect reported metrics.; Concentration risk in bancassurance — BALIC's largest bancassurance partner (Axis Bank) contributes 22% of business; the partner's acquisition of a competing insurer could pressure margins or market share.; Market volatility impacting investment gains — Lower realized gains in Q4 due to market conditions dragged PAT for both insurance subsidiaries; continued volatility could affect profitability.; Competitive pressure in tender-driven insurance lines — Aggressive pricing in crop and government health segments led BAGIC to reduce participation, risking market share loss in these lines..
- Promise ledger
- Of 2 tracked promises, management 0 met, 0 close, 2 missed.